Amedeo's Top 20

Amedeo Smart

Independent Medical Education

29 April 2019

Multidisciplinary Journal Club

  1. Wang CY, Wong WW, Tsai HC, Chen YH, et al.
    Effect of Anti-CD4 Antibody UB-421 on HIV-1 Rebound after Treatment Interruption.
    N Engl J Med 2019;380:1535-1545.

  1. Keulen JK, Bruinsma A, Kortekaas JC, van Dillen J, et al.
    Induction of labour at 41 weeks versus expectant management until 42 weeks (INDEX): multicentre, randomised non-inferiority trial.
    BMJ 2019;364:l344.

  2. Heerspink HJL, Parving HH, Andress DL, Bakris G, et al.
    Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
    Lancet 2019.

  3. Connolly SJ, Crowther M, Eikelboom JW, Gibson CM, et al.
    Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors.
    N Engl J Med 2019;380:1326-1335.

  4. Gattinoni L, Vasques F, Camporota L, Meessen J, et al.
    Understanding Lactatemia in Human Sepsis: Potential Impact for Early Management.
    Am J Respir Crit Care Med 2019.

  1. Dember LM, Lacson E Jr, Brunelli SM, Hsu JY, et al.
    The TiME Trial: A Fully Embedded, Cluster-Randomized, Pragmatic Trial of Hemodialysis Session Duration.
    J Am Soc Nephrol 2019.

  2. Sanyal AJ, Harrison SA, Ratziu V, Abdelmalek MF, et al.
    The Natural History of Advanced Fibrosis due to Nonalcoholic Steatohepatitis: Data from the Simtuzumab Trials.
    Hepatology 2019.

  3. Glare P, Aubrey KR, Myles PS.
    Transition from acute to chronic pain after surgery.
    Lancet 2019;393:1537-1546.

  4. Reindl-Schwaighofer R, Heinzel A, Kainz A, van Setten J, et al.
    Contribution of non-HLA incompatibility between donor and recipient to kidney allograft survival: genome-wide analysis in a prospective cohort.
    Lancet 2019;393:910-917.

  5. Cornec-Le Gall E, Alam A, Perrone RD.
    Autosomal dominant polycystic kidney disease.
    Lancet 2019;393:919-935.

  1. Mutz J, Vipulananthan V, Carter B, Hurlemann R, et al.
    Comparative efficacy and acceptability of non-surgical brain stimulation for the acute treatment of major depressive episodes in adults: systematic review and network meta-analysis.
    BMJ 2019;364:l1079.

  2. Perkovic V, Jardine MJ, Neal B, Bompoint S, et al.
    Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy.
    N Engl J Med 2019.

  3. Sandler KA, Cook RR, Ciezki JP, Ross AE, et al.
    Prostate-only Versus Whole-pelvis Radiation with or Without a Brachytherapy Boost for Gleason Grade Group 5 Prostate Cancer: A Retrospective Analysis.
    Eur Urol 2019.

  4. Robertson MM, Braunstein SL, Hoover DR, Li S, et al.
    Timeliness of HIV Diagnosis and Antiretroviral Treatment Initiation in the Era of Universal Test and Treat.
    J Infect Dis 2019.

  5. Souli M, Ruffin F, Choi SH, Park LP, et al.
    Changing Characteristics of Staphylococcus aureus Bacteremia: Results From a 21-Year, Prospective, Longitudinal Study.
    Clin Infect Dis 2019.

  1. Seiffge DJ, Paciaroni M, Wilson D, Koga M, et al.
    DOAC vs. VKA after recent ischemic stroke in patients with atrial fibrillation.
    Ann Neurol 2019.

  2. Voora S, Adey DB.
    Management of Kidney Transplant Recipients by General Nephrologists: Core Curriculum 2019.
    Am J Kidney Dis 2019.

  3. Ahern TP, Broe A, Lash TL, Cronin-Fenton DP, et al.
    Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study.
    J Clin Oncol 2019.

  4. Noordhoek I, de Groot AF, Cohen D, Liefers GJ, et al.
    Higher ER load is not associated with better outcome in stage 1-3 breast cancer: a descriptive overview of quantitative HR analysis in operable breast cancer.
    Breast Cancer Res Treat 2019.

  5. Corl KA, Prodromou M, Merchant RC, Gareen I, et al.
    The Restrictive IV Fluid Trial in Severe Sepsis and Septic Shock (RIFTS): A Randomized Pilot Study.
    Crit Care Med 2019.


Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016